Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 694-898-7 | CAS number: 23121-00-8
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Eye irritation
Administrative data
- Endpoint:
- eye irritation: in vitro / ex vivo
- Type of information:
- experimental study
- Adequacy of study:
- weight of evidence
- Study period:
- 07 - 28 Feb 2017
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- guideline study
Data source
Reference
- Reference Type:
- study report
- Title:
- Unnamed
- Year:
- 2 017
- Report date:
- 2017
Materials and methods
Test guideline
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 492 (Reconstructed Human Cornea-like Epithelium (RhCE) Test Method for Identifying Chemicals Not Requiring Classification and Labelling for Eye Irritation or Serious Eye Damage)
- Version / remarks:
- adopted in 2015
- Deviations:
- yes
- Remarks:
- No information on historical data given
- GLP compliance:
- yes (incl. QA statement)
- Remarks:
- Hess. Ministerium für Umwelt, Energie, Landwirtschaft und Verbraucherschutz, Wiesbaden, Germany
Test material
- Reference substance name:
- 4-(2-phenylpropan-2-yl)phenyl 4-oxo-3-(λ⁵-diazynylidene)-3,4-dihydronaphthalene-1-sulfonate
- Cas Number:
- 23121-00-8
- Molecular formula:
- C25H20N2O4S
- IUPAC Name:
- 4-(2-phenylpropan-2-yl)phenyl 4-oxo-3-(λ⁵-diazynylidene)-3,4-dihydronaphthalene-1-sulfonate
- Test material form:
- solid
Constituent 1
Test animals / tissue source
- Species:
- human
- Details on test animals or tissues and environmental conditions:
- - Justification of the test method and considerations regarding applicability
The reconstructed human cornea-like epithelium (RhCE) model is an accepted in vitro method to replace animal testing. The human eye EpiOcular™-model closely mimics the biochemical and physiological properties of the human eye, i.e. the cornea.
- Description of the cell system used, incl. certificate of authenticity and the mycoplasma status of the cell
The EpiOcular™ human cell construct (OCL-200, OCL-212, MatTek Corporation) is used in this assay. It is a nonkeratinized epithelium prepared from normal human keratinocytes. All biological components of the EpiOcular™ tissue and the kit culture medium have been tested and are free of contamination. Analyses for tissue functionality and quality (like barrier function, viability, morphology were performed and accepted.
Test system
- Vehicle:
- unchanged (no vehicle)
- Controls:
- yes, concurrent positive control
- yes, concurrent negative control
- Amount / concentration applied:
- TEST MATERIAL
- Amount(s) applied: 50 mg
- Concentration: neat/ undiluted - Duration of treatment / exposure:
- 6 h ± 15 min
- Observation period (in vivo):
- not applicable
- Duration of post- treatment incubation (in vitro):
- 25 ± 2 min (Post-exposure immersion incubation)
18 h ± 15 min (Post-treatment incubation) - Number of animals or in vitro replicates:
- 2 per test chemical and controls
- Details on study design:
- - Details of the test procedure used:
The cytotoxicity of the test item (and thus the ocular irritation potential) is evaluated by the relative viability of the treated RhCE tissues in comparison to the negative control-treated tissues. Viability is determined by the NAD(P)H-dependent microsomal enzyme reduction of MTT in control and test item treated cultures.
- RhCE tissue construct used, including batch number:
The EpiOcularTM human cell construct (OCL-200 and OCL-212, MatTek In Vitro Life Science Laboratories, Bratislava, Slovakia, Lot number: 23769)
- Doses of test chemical and control substances used:
50 mg test item; 50 μL positive control (methyl acetate) and 50 μL negative control (sterile deionized water)
- Duration and temperature of exposure, post-exposure immersion and post-exposure incubation periods:
6 h ± 15 min (Treatment/ exposure) at 37°C and 5% CO2
25 ± 2 min (Post-exposure immersion incubation) at room temperature
18 h ± 15 min (Post-treatment incubation) at 37°C and 5% CO2
- Wavelength used for quantifying MTT formazan:
570 nm
- Description of the method used to quantify MTT formazan:
Inserts were removed from the 24-well plate after the incubation time in MTT solution (1 mg/mL) (3 h ± 10 min), the bottom of the insert was blotted on absorbent material and transferred to a 6-well plate containing 2 mL isopropanol per well in a manner avoiding the isopropanol to flow into the insert. The plate was sealed with standard plate sealer. To extract the MTT, the plates were placed on an orbital plate shaker and shaken for 2-3 h at room temperature. 200 μL samples from each tube were placed into the wells of a 96-well plate and the absorbance/optical density was measured in a 96-well plate spectrophotometer to determine cell viability.
- Description of evaluation criteria used including the justification for the selection of the cut-off point for the prediction model:
The test item requires classification and labelling according to UN GHS (Category 2 or Category 1), if the mean percent tissue viability after exposure and post-exposure incubation is ≤ 60% of the negative control.
The test item requires no classification and labelling according to UN GHS (No Category), if the mean percent tissue viability after exposure and post-exposure incubation is > 60%.
- Reference to historical positive and negative control results demonstrating suitable run acceptance criteria:
No information is given on historical data, but the results obtained for the negative and positive control are meeting the acceptance criteria given in the OECD guideline 492.
- Complete supporting information for the specific RhCE tissue construct used:
Data of the Analysis for tissue functionality and quality is included in the study report.
- Reference to historical data of the RhCE tissue construct:
no further information available
- Demonstration of proficiency in performing the test method before routine use by testing of the proficiency chemicals:
no information provided
- Positive and negative control means and acceptance ranges based on historical data/ TG OECD 492:
negative control mean OD: 1.479 (acceptance range: 0.8 - 2.5)
positive control mean viablity: 46.9% (acceptance criteria: < 50% of the negative control)
- Acceptable variability between tissue replicates for positive and negative controls:
The variability between tissue replicates for positive and negative controls were 0.2 and 1.4% respectively, thus meeting the acceptance criteria of < 20%.
- Acceptable variability between tissue replicates for the test chemical
The variability between tissue replicates for the test chemical was 1.4, thus meeting the acceptance criteria of < 20%.
Results and discussion
In vitro
Resultsopen allclose all
- Irritation parameter:
- other: mean viability (% of negative control)
- Run / experiment:
- positive control
- Value:
- 46.9
- Vehicle controls validity:
- not applicable
- Negative controls validity:
- valid
- Positive controls validity:
- valid
- Irritation parameter:
- other: mean viability (% of negative control)
- Run / experiment:
- test item
- Value:
- 100.8
- Vehicle controls validity:
- not applicable
- Negative controls validity:
- valid
- Positive controls validity:
- valid
- Other effects / acceptance of results:
- OTHER EFFECTS:
- Visible damage on test system: no information provided
ACCEPTANCE OF RESULTS:
- Acceptance criteria met for negative control: Yes, as the mean OD value (1.490) of the two negative control tissues lies between 0.8 and 2.5.
- Acceptance criteria met for positive control: Yes, as the mean percentage viability for the positive control (46.9%) lies below 50% of the control viability.
Any other information on results incl. tables
Table 1: MTT results of eye irritation study
Controls |
|
Optical Density (OD) |
Viability (%) |
Δ% |
Negative Control: Sterile deionized water |
1 |
1.468 |
99.3 |
1.4 |
2 |
1.490 |
100.7 |
||
mean |
1.479 |
100.0 |
- |
|
standard deviation (SD) |
0.99 |
|
||
Positive Control: |
1 |
0.695 |
47.0 |
0.2 |
2 |
0.692 |
46.8 |
||
mean |
0.694 |
46.9 |
- |
|
standard deviation (SD) |
0.14 |
|
||
Test item |
1 |
1.501 |
101.5 |
1.4 |
2 |
1.480 |
100.1 |
||
mean |
1.491 |
100.8 |
- |
|
standard deviation (SD) |
0.99 |
- |
Applicant's summary and conclusion
- Interpretation of results:
- other: CLP/ EU GHS criteria not met, no classification required according to Regulation (EC) No 1272/2008
- Conclusions:
- CLP: not classified
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.